Performance Evaluation and Measurement Uncertainty Determination of the New Version of the Abbott ARCHITECT 25-OH Vitamin D 5P02 Assay
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Clinical Pathology"
DOI: 10.1093/ajcp/aqy131
Abstract: Objectives We evaluated performance and measurement uncertainty of the newly released ARCHITECT 25-OH vitamin D 5P02 assay (Abbott Diagnostics, Abbott Park, IL). Methods In total, 300 samples were used to compare the results from ELECSYS… read more here.
Keywords: uncertainty; performance; architect; vitamin ... See more keywords
Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring
Sign Up to like & getrecommendations! Published in 2017 at "Therapeutic Drug Monitoring"
DOI: 10.1097/ftd.0000000000000434
Abstract: Background: Fluorescence polarization immunoassay (FPIA) has probably been the most widely used technique for the determination of methotrexate (MTX) concentrations in clinical laboratories. After its replacement by a novel architect chemiluminescent microparticle immunoassay (CMIA), it… read more here.
Keywords: mgr mol; methotrexate; architect chemiluminescent; mtx ... See more keywords
Design Efficacy and Exploration Behavior of Student Architect-Engineer Design Teams in Shared Parametric Environments
Sign Up to like & getrecommendations! Published in 2023 at "Buildings"
DOI: 10.3390/buildings13051296
Abstract: Increasingly, architects and building engineers use parametric modeling programs to explore design solutions as professionals and as students. However, little is known about their combined efficacy and exploration in these tools when working in mixed… read more here.
Keywords: architect; efficacy exploration; efficacy; design ... See more keywords